Lucie Raskin: New FAERS Evidence Suggests Lower VTE Risk With Natural Estrogen COCs
Lucie Raskin, PhD student at University of Namur, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”New publication accepted in the American Journal of Obstetrics and Gynecology.
Our disproportionality analysis of the FAERS database provides new evidence suggesting that combined oral contraceptives containing natural estrogens may represent safer options regarding venous thromboembolic risk.
Pleased to share this work with Marie Didembourg, Jean-Michel Dogné, Mitchell Creinin, Médéa Locuet.
Special thanks to my promotors Jonathan Douxfils and Charlotte Beaudart.”
Title: Venous Thromboembolism with Combined Oral Contraceptives Based on Estrogen and Progestin Content: A disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database
Authors: Lucie Raskin, Marie Didembourg, Jean-Michel Dogné, Médéa Locquet, Mitchell D. Creinin, Charlotte Beaudart, Jonathan Douxfils
Read the Full Article on American Journal of Obstetrics and Gynecology
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 20, 2026, 12:14Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
-
Apr 20, 2026, 12:09Syed Sibtain Raza: White Blood Cells – Understanding Morphology for Better Diagnosis
-
Apr 20, 2026, 11:23Bastu Odoka: Jehovah’s Witness News on Transfusion… and a Question Worth Asking
-
Apr 20, 2026, 11:15William Aird: A Physiological Approach to Anemia
-
Apr 20, 2026, 10:59Eric Topol: Is the Interferon Pathway a Key Driver of Inflammaging and Aging
-
Apr 20, 2026, 10:47Emmanuel J Favaloro: Emerging Perspectives on Extracellular Vesicles in Hemophilia
-
Apr 20, 2026, 10:21Pierpaolo Di Micco: Honored to Join the ESVM Congress in Lausanne
-
Apr 20, 2026, 08:17Heghine Khachatryan: Key Takeaways from Day 1 – WFH 2026 World Congress
-
Apr 20, 2026, 08:10Justin Nelson-Deering։ Celebrating World Hemophilia Day in Pediatric Care